SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-17-004287
Filing Date
2017-01-26
Accepted
2017-01-26 16:02:15
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 a17-3162_1s3.htm S-3 361056
2 EX-4.13 a17-3162_1ex4d13.htm EX-4.13 9159
3 EX-5.1 a17-3162_1ex5d1.htm EX-5.1 8508
4 EX-23.1 a17-3162_1ex23d1.htm EX-23.1 2455
5 GRAPHIC g31621kg03i001.gif GRAPHIC 54127
6 GRAPHIC g31621kg01i001.gif GRAPHIC 336606
  Complete submission text file 0001104659-17-004287.txt   920241
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-215747 | Film No.: 17549708
SIC: 2835 In Vitro & In Vivo Diagnostic Substances